243
Views
3
CrossRef citations to date
0
Altmetric
Original

The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose–rate irradiation with γ-rays

, , , , , , , & show all
Pages 29-35 | Received 15 Aug 2006, Accepted 17 Nov 2006, Published online: 09 Jul 2009

References

  • Vaupel P, Kelleher DK, Hoeckel M. Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001; 28(Suppl 8)29–35
  • Masunaga S, Ono K. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res 2002; 43: 11–25
  • Masunaga S, Ono K, Abe M. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumors. Br J Radiol 1993; 66: 918–926
  • Hall EL. Repair of radiation damage and the dose-rate effect. Radiobiology for the radiologist6th, EL Hall. Lippincott Williams & Wilkins, Philadelphia 2006; 60–84
  • Masunaga S, Ono K, Hori H. Exploiting tumor hypoxia in the treatment of solid tumors. Jpn J Hyperthermic Oncol 2001; 17: 13–22
  • Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumor cell populations. Int J Hyperthermia 2005; 21: 305–318
  • Griffin RJ, Okajima K, Ogawa A, Song CW. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing. Int J Radiat Biol 1999; 75: 1299–1306
  • Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y. Modification of tirapazamine-induced cytotoxicity in combination with mild Hyperthermia and/or nicotinamide: Reference to effect on quiescent tumour cells. Int J Hyperthermia 1999; 15: 7–16
  • Masunaga S, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, Hori H, Nagasawa H, Tsuchiya I, Sadahiro S, et al. Radiosensitization effect by combination with paclitaxel in vivo including the effect on intratumor quiescent cells. Int J Radiat Oncol Biol Phys 2001; 50: 1063–1072
  • International Commision on Radiation Units and Measurements. ICRU Report 58, Dose and volume specification for reporting interstitial therapy. ICRU. Bethesda, (Maryland) 1997
  • Nishimura Y, Ono K, Hiraoka M, Masunaga S, Jo S, Shibamoto Y, Sasai K, Abe M, Iga K, Ogawa Y. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat Res 1990; 122: 161–167
  • Hall EL. Cell survival curves. Radiobiology for the radiologist6th, EL Hall. Lippincott Williams & Wilkins, Philadelphia 2006; 30–46
  • Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, Gastpar R, Issels RD. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002; 18: 563–575
  • Wang Z, Armour EP, Corry PM, Martinez A. Elimination of dose-rate effects by mild hyperthermia. Int J Radiat Oncol Biol Phys 1992; 24: 965–973
  • Ryu S, Brown SL, Kolozsvary A, Kim JH. Increased tumour response of a murine fibrosarcoma to low temperature hyperthermia and low dose rate brachytherapy. Int J Hyperthermia 1996; 12: 635–643
  • Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004; 14: 197–275
  • Rosenberg A, Knox S. Radiation sensitization with redox modulators: A promising approach. Int J Radiat Oncol Biol Phys 2006; 64: 343–354

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.